Connection

PAUL HOPKINS to Triglycerides

This is a "connection" page, showing publications PAUL HOPKINS has written about Triglycerides.
Connection Strength

0.570
  1. Assessment of postprandial triglycerides in clinical practice: Validation in a general population and coronary heart disease patients. J Clin Lipidol. 2016 Sep-Oct; 10(5):1163-71.
    View in: PubMed
    Score: 0.108
  2. The relation between erythrocyte trans fat and triglyceride, VLDL- and HDL-cholesterol concentrations depends on polyunsaturated fat. PLoS One. 2012; 7(10):e47430.
    View in: PubMed
    Score: 0.084
  3. The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs. J Lipid Res. 2008 Aug; 49(8):1839-45.
    View in: PubMed
    Score: 0.062
  4. The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment. Eur J Hum Genet. 2008 May; 16(5):603-13.
    View in: PubMed
    Score: 0.061
  5. Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state. J Lipid Res. 2000 Sep; 41(9):1428-36.
    View in: PubMed
    Score: 0.036
  6. Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36. J Lipid Res. 2016 12; 57(12):2176-2184.
    View in: PubMed
    Score: 0.028
  7. Caveolin 1 Modulates Aldosterone-Mediated Pathways of Glucose and Lipid Homeostasis. J Am Heart Assoc. 2016 09 28; 5(10).
    View in: PubMed
    Score: 0.028
  8. Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate. PLoS One. 2012; 7(10):e48663.
    View in: PubMed
    Score: 0.021
  9. The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate. J Cardiovasc Pharmacol. 2012 Mar; 59(3):254-9.
    View in: PubMed
    Score: 0.020
  10. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study. Lipids Health Dis. 2011 Oct 18; 10:181.
    View in: PubMed
    Score: 0.020
  11. Association of gene variants with lipid levels in response to fenofibrate is influenced by metabolic syndrome status. Atherosclerosis. 2011 Apr; 215(2):435-9.
    View in: PubMed
    Score: 0.019
  12. Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study. J Lipid Res. 2010 Nov; 51(11):3316-23.
    View in: PubMed
    Score: 0.018
  13. Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis. 2009 Apr; 203(2):633-9.
    View in: PubMed
    Score: 0.016
  14. Evidence of QTL on 15q21 for high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study (NHLBI FHS). Atherosclerosis. 2007 Jan; 190(1):232-7.
    View in: PubMed
    Score: 0.013
  15. Familial clustering for features of the metabolic syndrome: the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study. Diabetes Care. 2006 Mar; 29(3):631-6.
    View in: PubMed
    Score: 0.013
  16. Segregation analysis of HDL cholesterol in the NHLBI Family Heart Study and in Utah pedigrees. Eur J Hum Genet. 2002 Jun; 10(6):367-74.
    View in: PubMed
    Score: 0.010
  17. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001 Jan 02; 103(1):102-7.
    View in: PubMed
    Score: 0.009
  18. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis. 1989 May-Jun; 9(3):335-44.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.